GENI vs. AGX

Last updated Jun 4, 2026

GENI (Genius Sports Limited) and AGX (Argan, Inc.) are both stocks. GENI operates in Internet Content & Information (Communication Services), while AGX operates in Engineering & Construction (Industrials). Over the past 5 years, GENI returned -22.69%/yr vs 73.16%/yr for AGX. At a 0.17 correlation, their price movements are largely independent.

Performance

GENI vs. AGX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Genius Sports Limited (GENI) and Argan, Inc. (AGX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, GENI achieves a -46.55% return, which is significantly lower than AGX's 119.52% return.

GENI

• 1D: -3.28%
• 1M: 30.89%
• YTD: -46.55%
• 6M: -47.97%
• 1Y: -37.61%
• 3Y*: 0.98%
• 5Y*: -22.69%
• 10Y*: —

AGX

• 1D: 3.50%
• 1M: -1.55%
• YTD: 119.52%
• 6M: 95.90%
• 1Y: 215.63%
• 3Y*: 159.29%
• 5Y*: 73.16%
• 10Y*: 38.58%

*Multi-year figures are annualized to reflect compound growth (CAGR)

GENI vs. AGX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
GENI Genius Sports Limited	-46.55%	27.40%	39.97%	73.11%	-53.03%	-61.58%
AGX Argan, Inc.	119.52%	130.61%	198.31%	30.24%	-2.01%	-25.26%

Correlation

The correlation between GENI and AGX is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.11
Correlation (3Y) Calculated over the trailing 3-year period	0.16
Correlation (5Y) Calculated over the trailing 5-year period	0.17
Correlation (All Time) Calculated using the full available price history since Apr 22, 2021	0.17

Fundamentals

Market Cap GENI : $1.59B AGX : $9.73B
EPS GENI : -$0.61 AGX : $9.73
PS Ratio GENI : 2.15 AGX : 10.29
PB Ratio GENI : 2.28 AGX : 21.06
Total Revenue (TTM) GENI : $713.45M AGX : $944.61M
Gross Profit (TTM) GENI : $161.30M AGX : $193.68M
EBITDA (TTM) GENI : -$70.25M AGX : $134.70M

Return for Risk

GENI vs. AGX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GENI

GENI Risk / Return Rank: 19
GENI Sharpe Ratio Rank: 16
GENI Sortino Ratio Rank: 18
GENI Omega Ratio Rank: 18
GENI Calmar Ratio Rank: 23
GENI Martin Ratio Rank: 21

AGX

AGX Risk / Return Rank: 93
AGX Sharpe Ratio Rank: 94
AGX Sortino Ratio Rank: 91
AGX Omega Ratio Rank: 89
AGX Calmar Ratio Rank: 96
AGX Martin Ratio Rank: 96

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GENI vs. AGX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Genius Sports Limited (GENI) and Argan, Inc. (AGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GENI	AGX	Difference
Sharpe ratio Return per unit of total volatility	-0.59	2.91	-3.51
Sortino ratio Return per unit of downside risk	-0.59	3.46	-4.05
Omega ratio Gain probability vs. loss probability	0.92	1.43	-0.51
Calmar ratio Return relative to maximum drawdown	-0.53	8.70	-9.23
Martin ratio Return relative to average drawdown	-0.98	22.97	-23.96
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GENI vs. AGX - Sharpe Ratio Comparison

The current GENI Sharpe Ratio is -0.59, which is lower than the AGX Sharpe Ratio of 2.91. The chart below compares the historical Sharpe Ratios of GENI and AGX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	GENI	AGX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.59	2.91	-3.51
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.34	1.45	-1.79
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.84	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.32	0.05	-0.37

Drawdowns

GENI vs. AGX - Drawdown Comparison

The maximum GENI drawdown since its inception was -90.97%, roughly equal to the maximum AGX drawdown of -94.37%. Use the drawdown chart below to compare losses from any high point for GENI and AGX.

Drawdown Indicators

	GENI	AGX	Difference
Max Drawdown Largest peak-to-trough decline	-90.97%	-94.37%	+3.40%
Max Drawdown (1Y) Largest decline over 1 year	-71.07%	-24.96%	-46.11%
Max Drawdown (3Y) Largest decline over 3 years	-71.07%	-43.75%	-27.32%
Max Drawdown (5Y) Largest decline over 5 years	-89.95%	-43.75%	-46.20%
Max Drawdown (10Y) Largest decline over 10 years	—	-54.61%	—
Current Drawdown Current decline from peak	-76.37%	-7.36%	-69.01%
Average Drawdown Average peak-to-trough decline	-67.22%	-48.37%	-18.85%
Ulcer Index Depth and duration of drawdowns from previous peaks	38.33%	9.43%	+28.90%

Volatility

GENI vs. AGX - Volatility Comparison

Genius Sports Limited (GENI) has a higher volatility of 27.42% compared to Argan, Inc. (AGX) at 15.08%. This indicates that GENI's price experiences larger fluctuations and is considered to be riskier than AGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GENI	AGX	Difference
Volatility (1M) Calculated over the trailing 1-month period	27.42%	15.08%	+12.34%
Volatility (6M) Calculated over the trailing 6-month period	55.90%	54.58%	+1.32%
Volatility (1Y) Calculated over the trailing 1-year period	63.57%	74.56%	-10.99%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	66.96%	50.62%	+16.34%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	67.15%	46.01%	+21.14%

Dividends

GENI vs. AGX - Dividend Comparison

GENI has not paid dividends to shareholders, while AGX's dividend yield for the trailing twelve months is around 0.27%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
AGX Argan, Inc.	0.27%	0.52%	0.93%	2.24%	2.71%	1.94%	7.31%	2.49%	1.98%	4.44%	1.42%	2.16%
GENI Genius Sports Limited	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

GENI vs. AGX - Profitability Comparison

The chart below illustrates the profitability comparison between Genius Sports Limited and Argan, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

GENI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Genius Sports Limited reported a gross profit of 42.99M and revenue of 187.95M. Therefore, the gross margin over that period was 22.9%.

AGX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported a gross profit of 65.60M and revenue of 262.05M. Therefore, the gross margin over that period was 25.0%.

GENI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Genius Sports Limited reported an operating income of -29.63M and revenue of 187.95M, resulting in an operating margin of -15.8%.

AGX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported an operating income of 47.67M and revenue of 262.05M, resulting in an operating margin of 18.2%.

GENI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Genius Sports Limited reported a net income of -55.47M and revenue of 187.95M, resulting in a net margin of -29.5%.

AGX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported a net income of 49.21M and revenue of 262.05M, resulting in a net margin of 18.8%.

Frequently Asked Questions

Can I hold both GENI and AGX in my portfolio?

GENI and AGX have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, GENI or AGX?

GENI has higher volatility (27.42%) compared to AGX (15.08%). In terms of maximum drawdown, GENI dropped -90.97% vs AGX's -94.37%.

Which has better risk-adjusted returns?

AGX currently has the higher Sharpe Ratio (2.91 vs -0.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.